bismuth has been researched along with Bile Duct Cancer in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (13.79) | 24.3611 |
2020's | 25 (86.21) | 2.80 |
Authors | Studies |
---|---|
Asano, T; Ebihara, Y; Hirano, S; Kurashima, Y; Matsui, A; Murakami, S; Nakamura, T; Nakanishi, Y; Noji, T; Okamura, K; Shichinohe, T; Tanaka, K; Tsuchikawa, T; Watanabe, Y | 1 |
Cao, X; Fan, S; Yang, L; Zhang, X | 1 |
Chen, Z; Dai, H; Fan, H; Hu, F; Jiang, Y; Lei, X; Li, Y; Lin, H; Liu, X; Song, J; Zhang, C; Zhang, L | 1 |
Aydin, C; Carr, BI; Ersan, V; Karatoprak, S; Usta, S; Yilmaz, S | 1 |
Byun, Y; Choi, YJ; Han, Y; Jang, JY; Kang, JS; Kim, H; Kwon, W; Lee, JM; Sohn, HJ | 1 |
Jiang, N; Jin, S; Wang, SY; Xiang, CH; Xiao, Y; Yu, SQ; Zeng, JP; Zhou, CY | 1 |
Hosokawa, I; Ohtsuka, M; Takayashiki, T | 1 |
Akimoto, Y; Fujii, M; Fujii, Y; Ishida, E; Ishihara, Y; Kato, H; Kawamoto, H; Matsumoto, K; Mitsuhashi, T; Ogawa, T; Seki, H; Yamazaki, T | 1 |
Cui, L; Jiang, XC; Li, HS; Liu, YS; Qi, DF; Zhang, J | 1 |
Dai, YS; He, ZQ; Hu, HJ; Hu, YF; Li, FY; Lv, TR | 1 |
Ausania, F; Bermúdez, P; Burrel, M; Carrero, E; Fondevila, C; Gómez, FM; Hessheimer, A; Molina, V; Moreno, J; Páez-Carpio, A; Serrano, E; Zarco, FX | 1 |
Ahn, KS; Bae, J; Cho, KB; Kang, KJ; Kim, TS; Kim, YH; Shin, DW | 1 |
Liu, Z; Lu, Z; Sun, W; Wang, D; Zhang, D; Zhou, S | 1 |
Caracciolo, D; Catellani, B; Di Benedetto, F; Di Sandro, S; Guerrini, GP; Guidetti, C; Magistri, P; Odorizzi, R; Pang, NQ | 1 |
Hu, Z; Li, A; Liang, Y; Liu, J; Liu, X; Qin, J; Su, L; Xing, Z; Xu, H; Zhou, X | 1 |
Guan, J; Li, X; Liu, D; Xu, Z; Zhang, Z; Zhou, Z | 1 |
Ku, D; Lam, V; Pang, T; Pleass, H; Richardson, A; Tang, R; Yuen, L | 1 |
Hosokawa, I; Shimizu, H | 1 |
Cheng, NS; Li, FY; Ma, WJ | 1 |
Chen, RX; Li, CX; Li, XC | 1 |
Basile, F; Donati, M; Zanatta, M | 1 |
Fang, C; Hu, H; Qi, S; Wen, S; Xiang, N; Yang, J; Zeng, N; Zeng, S; Zhu, W | 1 |
Alaimo, L; Bagante, F; Ruzzenente, A | 1 |
Aldrighetti, L; Alikhanov, R; Bagante, F; Cescon, M; Guglielmi, A; Iacono, C; Jarnagin, WR; Koerkamp, BG; Lang, H; Nadalin, S; Olthof, PB; Pratschke, J; Ruzzenente, A; Schmelzle, M; Sparrelid, E; van Gulik, TM | 1 |
Chen, W; He, M; Xu, X; Yang, L | 1 |
Chen, W; He, M; Wang, HL; Wang, J; Xu, SW; Yan, JY | 1 |
Lu, Z; Wang, DD | 1 |
Fujiwara, H; Ichikawa, D; Ikoma, H; Komatsu, S; Konishi, H; Kosuga, T; Kriu, Y; Mizutani, T; Morimura, R; Murayama, Y; Nakanishi, M; Ochiai, T; Okamoto, K; Otsuji, E; Shiozaki, A | 1 |
Ji, GW; Jiao, CY; Li, XC; Shao, ZC; Wang, K; Zhu, FP | 1 |
2 review(s) available for bismuth and Bile Duct Cancer
Article | Year |
---|---|
Should more aggressive surgical resection be considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysis.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies; Treatment Outcome | 2023 |
Survival outcomes of hepatic resections in Bismuth-Corlette type IV cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Retrospective Studies; Treatment Outcome | 2020 |
1 trial(s) available for bismuth and Bile Duct Cancer
Article | Year |
---|---|
Bilateral verses bilateral with tri-segmental endoscopic drainage using metal stents for high-grade malignant hilar biliary obstructions: A multicenter, randomized controlled trial: BRAVE study (BRAVE study).
Topics: Bile Duct Neoplasms; Bismuth; Cholestasis; Drainage; Humans; Stents; Treatment Outcome | 2022 |
26 other study(ies) available for bismuth and Bile Duct Cancer
Article | Year |
---|---|
Clinical and oncological benefits of left hepatectomy for Bismuth type I/II perihilar cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies | 2022 |
The "Hand as Foot" teaching method in Bismuth-Corlette classification of hilar cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies | 2022 |
Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Humans; Klatskin Tumor; Lymphatic Metastasis; Retrospective Studies | 2022 |
Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Humans; Klatskin Tumor; Retrospective Studies | 2023 |
Impact of surgery on survival outcomes for Bismuth type IV Klatskin tumors.
Topics: Bile Duct Neoplasms; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies; Treatment Outcome | 2022 |
Patterns of Caudate Lobe Invasion of Hilar Cholangiocarcinoma: A Panoramic Histologic Study of Liver.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Eosine Yellowish-(YS); Hematoxylin; Hepatectomy; Humans; Klatskin Tumor; Liver | 2022 |
Fusion imaging of real-time ultrasonography and computed-tomography-assisted puncture of the bile duct of segment 6 for Bismuth-Corlette type IV perihilar cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Punctures; Retrospective Studies; Tomography; Ultrasonography | 2023 |
Total three-dimensional laparoscopic radical resection for Bismuth type IV hilar cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Laparoscopy; Retrospective Studies; Treatment Outcome | 2023 |
Percutaneous transhepatic biliary drainage for biliary obstruction in perihilar cholangiocarcinoma: a 10-year analysis of safety and outcomes using the CCI index.
Topics: Bile Duct Neoplasms; Bismuth; Cholestasis; Drainage; Humans; Klatskin Tumor; Postoperative Complications | 2023 |
Survival outcome of surgical resection compared to non-resection for Bismuth type IV perihilar cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Margins of Excision; Retrospective Studies; Treatment Outcome | 2023 |
Application of mesohepatectomy with caudate lobectomy for the treatment of type III-IV hilar cholangiocarcinoma: a single-center retrospective study.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Humans; Klatskin Tumor; Retrospective Studies; Treatment Outcome | 2023 |
Robotic approach for perihilar cholangiocarcinoma: from Bismuth 1 to vascular resection.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Robotic Surgical Procedures; Robotics | 2023 |
Application of a New Approach for Laparoscopic Resection of Bismuth IIIa Hilar Cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Laparoscopy; Liver; Retrospective Studies; Treatment Outcome | 2023 |
Prognostic analysis and outcome of hilar cholangiocarcinoma after radical resection: a retrospective study.
Topics: Bile Duct Neoplasms; Bismuth; Humans; Klatskin Tumor; Prognosis; Retrospective Studies | 2023 |
ASO Author Reflections: Left Trisectionectomy for Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma with Left-Sided Predominance.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies | 2020 |
When Should Hepatectomy be Performed for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma?
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies; Treatment Outcome | 2020 |
Reply to: "When Should Hepatectomy be Performed for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma?"
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies; Treatment Outcome | 2020 |
Is the Bismuth-Corlette IIIb stage really an unfavorable situation for resectability of Klatskin tumors? A critical appraisal.
Topics: Bile Duct Neoplasms; Bismuth; Humans; Klatskin Tumor | 2020 |
[Application of 3D visualization and 3D printing in individualized precision surgery for Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Imaging, Three-Dimensional; Klatskin Tumor; Liver Neoplasms; Portal Vein; Printing, Three-Dimensional; Retrospective Studies | 2020 |
The Role of Surgery in the Treatment of Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Humans; Klatskin Tumor | 2021 |
Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group.
Topics: Bile Duct Neoplasms; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies | 2021 |
Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.
Topics: Bile Duct Neoplasms; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Retrospective Studies; Treatment Outcome | 2021 |
[The safety and effect of transhepatic hilar approach for the treatment of bismuth type Ⅲ and Ⅳ hilar cholangiocarcinoma].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholangiocarcinoma; Hepatectomy; Humans; Klatskin Tumor; Prognosis; Retrospective Studies; Treatment Outcome | 2018 |
[Operation treatment method of Bismuth-Corlette Ⅲ, Ⅳ hilar cholangiocarcinoma].
Topics: Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Hepatectomy; Humans; Klatskin Tumor; Ligaments; Lymph Node Excision | 2016 |
[A Case of Bismuth III b Hilar Cholangiocarcinoma Resected with Extended Left Hepatic Lobectomy after ERCP Induced Pancreatitis].
Topics: Aged; Bile Duct Neoplasms; Bismuth; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Hepatectomy; Humans; Male; Pancreatitis | 2016 |
Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bismuth; Cholestasis; Female; Hepatectomy; Hepatic Duct, Common; Humans; Imaging, Three-Dimensional; Klatskin Tumor; Male; Middle Aged; Organ Size; Portal Vein; Retrospective Studies | 2017 |